Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa.
about
Induction of interferon-λ contributes to TLR3 and RIG-I activation-mediated inhibition of herpes simplex virus type 2 replication in human cervical epithelial cells.Characterization of natural killer cell phenotype and function during recurrent human HSV-2 infection.Prophylactic and therapeutic modulation of innate and adaptive immunity against mucosal infection of herpes simplex virusTLR4-MyD88/Mal-NF-kB axis is involved in infection of HSV-2 in human cervical epithelial cells.Interleukin-21 receptor signalling is important for innate immune protection against HSV-2 infections.HSV-2 increases TLR4-dependent phosphorylated IRFs and IFN-β induction in cervical epithelial cellsDysbiosis-induced IL-33 contributes to impaired antiviral immunity in the genital mucosaHuman herpesviridae methods of natural killer cell evasionComparison of the host immune response to herpes simplex virus 1 (HSV-1) and HSV-2 at two different mucosal sites.Unique features of antiviral immune system of the vaginal mucosaTargeting the genital tract mucosa with a lipopeptide/recombinant adenovirus prime/boost vaccine induces potent and long-lasting CD8+ T cell immunity against herpes: importance of MyD88.Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.CD4 T cell responses in latent and chronic viral infections.Complement Opsonization Promotes Herpes Simplex Virus 2 Infection of Human Dendritic Cells.Antiviral activity of trappin-2 and elafin in vitro and in vivo against genital herpes.Ex vivo 2D and 3D HSV-2 infection model using human normal vaginal epithelial cells.Evolutionary-developmental perspectives on immune system interactions among the pregnant woman, placenta, and fetus, and responses to sexually transmitted infectious agents.The ongoing pursuit of a prophylactic HSV vaccine.Herpes simplex virus and HIV: genital infection synergy and novel approaches to dual prevention.Bioactive activities of natural products against herpesvirus infection.O-linked sugars sound the alarm.Anti-herpes simplex virus activity of polysaccharides from Eucheuma gelatinae.Extracellular vesicles: novel vehicles in herpesvirus infection.Effects of spatiotemporal HSV-2 lesion dynamics and antiviral treatment on the risk of HIV-1 acquisition.Herpes simplex virus type 2 infection triggers AP-1 transcription activity through TLR4 signaling in genital epithelial cells
P2860
Q30683907-F560DD12-A74E-4139-8F76-7D020117CBA6Q34081693-ABCE7B2F-3572-4D1C-A6AF-65500721F960Q34105712-FAED8D91-87BC-43F9-A5A7-3936A4696F5FQ35053550-C9EF5301-7D70-4091-BDF0-17159862EE6FQ35072560-B18BC223-A43C-4167-A067-34F2967AE500Q35145592-9E6A401C-77C9-4943-8E4A-F5E4DDABAD6DQ35904651-52C289DE-0F58-4C29-94C9-3B9101588764Q36102137-94290B0B-7A22-45A8-B7C9-D2C7D8DF634FQ36155593-E9664DF3-6373-4B5C-ADA4-F3F793D0983DQ36177229-7CB1CB8B-79DD-4A9F-930C-8E65345ABB46Q36339059-7D6E7EA7-419B-4737-A512-6A517C8A5276Q36555158-AAD34E64-DC31-41A4-9234-2304EEBDAF27Q36837631-8FB85285-1154-4BD8-B4A5-5D8BBE645D83Q36878921-12BD2236-47CF-46B6-BEDE-8304797E2F2EQ36978882-7B7FDEA7-F7C9-40BD-96D9-D1D99D85F047Q37716535-CA327929-C7F7-46AA-B1EE-D564AFD4EF59Q37913474-DF47E0E4-8E49-423F-8106-E4EEB0F259C2Q37991272-5A68772E-2A62-4F32-870F-8F23DA890E25Q38049148-1125DDB9-A395-42D7-A407-62626B3A9747Q38156673-58F30CBC-42EF-4A95-AC08-19C502FCCA8AQ40966280-5430032D-828D-429E-B00F-706DE895C806Q41532519-0151EB0A-10AD-452D-8260-2F014D62C8BFQ47586766-6276C645-C829-4ABA-A76C-9E9979651DCEQ52561266-C5A6D29B-4F46-443F-9470-645D5B564554Q59136245-4E00B74E-96FE-425B-BDF9-B51C34867835
P2860
Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa.
@en
Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa.
@nl
type
label
Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa.
@en
Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa.
@nl
prefLabel
Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa.
@en
Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa.
@nl
P2093
P1476
Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa
@en
P2093
Amanda J Lee
Nicole G Barra
Tiffany Chan
P304
P356
10.1016/J.JRI.2011.01.001
P50
P577
2011-02-21T00:00:00Z